Drugs in palliative care: Results from a representative survey in Germany

Palliative Medicine

Volumn 18, Issue 2, 2004, Pages 100-107

  Nauck, Friedemann ^a   Ostgathe, Christoph ^a   Klaschik, Eberhard ^a   Bausewein, Claudia ^b   Fuchs, Martin ^c   Lindena, Gabriele ^d   Neuwöhner, Karl ^e   Schulenberg, Dieter ^f   Radbruch, Lukas ^g  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c St Elisabeth Hospital   (Germany)

^d Clinical Analysis Res/Application   (Germany)

^e Palliative Care Unit   (Germany)

^f German Cancer Society   (Germany)

^g UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Drugs; Nonopioids; Opioids; Palliative care units; Survey; Sympton management

Indexed keywords

AMIODARONE; AMITRIPTYLINE; AMOXICILLIN; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CORTICOSTEROID; DEXAMETHASONE; DIPYRONE; DIURETIC AGENT; FENTANYL; FUROSEMIDE; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; HALOPERIDOL; LACTULOSE; LAXATIVE; LOPERAMIDE; LORAZEPAM; MACROGOL; METOCLOPRAMIDE; MORPHINE; NEUROLEPTIC AGENT; OMEPRAZOLE; OPIATE; PANTOPRAZOLE; PICOSULFATE SODIUM; ROFECOXIB; SEDATIVE AGENT; UNINDEXED DRUG;

ADULT; AGE; AGED; ARTICLE; AUSTRIA; CANCER PAIN; CULTURAL FACTOR; DEATH; DEPRESSION; DRUG USE; EUROPE; FEMALE; GERMANY; HEALTH CARE AVAILABILITY; HEALTH CARE QUALITY; HEALTH STATUS; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; PALLIATIVE THERAPY; PRESCRIPTION; SEX DIFFERENCE; SWITZERLAND; SYMPTOM; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; DRUG UTILIZATION; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PHARMACEUTICAL PREPARATIONS;

EID: 1642306527     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269216304pm852oa     Document Type: Article

References (20)

1. Determann MM, Rzehak P, Küchler T, et al. Qualitätssicherung in der Palliativmedizin. Forum Dtsch Krebsges 2000; 15: 10-13.
2. Radbruch L, Nauck F, Fuchs M, Neuwöhner K, Schulenberg D, Lindena G. What is palliative care in Germany? Results from a representative survey. J Pain Symptom Manage 2002; 23: 470-82.
3. Sabatowski R, Radbruch L, Nauck F, Müller M. Hospiz-und Palliativführer 2002. Neu-Isenburg: MediMedia Verlag, 2001.
4. Radbruch L, Nauck F, Ostgathe C, et al. What are the problems in palliative care? Results from a representative survey. Support Care Cancer 2003; 11: 442-51.
5. Radbruch L, Ostgathe C, Elsner F, et al. Prozeduren und Interventionen auf den deutschen Palliativstationen-Ergebnisse der Kerndokumentation 2001. Schmerz, in press.
6. Sabatowski R, Radbruch L, Loick G, Nauck F, Müller M. Palliativ 2000 - Stationäre und ambulanten Palliativ-und Hospizeinrichtungen in Deutschland. Limburg: Mundipharma GmbH, 1999.
7. BPI BdPI. Rote Liste 2001, Arzneimittelverzeichnis für Deutschland. Frankfurt/Main: Rote Liste Service GmbH, 2001.
8. WHO CCfDSM. Guidelines for ATC classification and DDD assignment. Oslo: World Health Organisation, 2001.
9. Klaschik E, Ostgathe C, Nauck F. Grundlagen und Selbstverständnis der Palliativmedizin. Z Palliativmed 2001; 2: 71-75.
10. Twycross R, Bergl S, John S, Lewis K. Monitoring drug use in palliative care. Palliat Med 1994; 8: 137-43.
11. Koh N, Koo W. Polypharmacy in palliative care: Can it be reduced? Singapore Med J 2002; 43: 279-83.
12. Dickerson D. The 20 essential drugs in palliative care. Eur J Palliat Care 1999; 6: 130-35.
13. Cherny N. New strategies in opioid therapy for cancer pain. J Oncol Manage 2000; 9: 8-15.
14. Hanks GW, Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001; 84: 587-93.
15. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1000 patients. Support Care Cancer 2000; 8: 175-79.
16. Nauck F. Symptomkontrolle in der Finalphase. Symptom control in the terminal phase. Schmerz 2001; 15: 362-69.
17. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care 1990; 6: 7-15.
18. Adam J. The last 48 hours. BMJ 1997; 315: 1600-603.
19. Twycross G, Lichter I. The terminal phase. In McDonald N, ed. Oxford textbook of palliative medicine, second edition. Oxford: Oxford University Press, 1998: 977-90.
20. WHO. Ninth Report of the WHO Expert Committee. The use of essential drugs. Geneva: World Health Organisation, 2000.